Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach
Yayoi Kimura(Yokohama City University Medical Center), Akihide Ryo(National Institute of Infectious Diseases), Takeharu Yamanaka(National Cancer Center Hospital East), Mototsugu Nishii(Yokohama City University), Jihye Shin(Yokohama City University Medical Center), Sundararaj Stanleyraj Jeremiah(Yokohama City University), Kayano Moriyama(Yokohama City University Medical Center), Ryo Saji(Yokohama City University), Kota Murohashi(Kanagawa Cardiovascular and Respiratory Center), Takeshi Kaneko(Yokohama City University), Yoko Ino(Yokohama City University), Tomoko Akiyama(Yokohama City University Medical Center), Yuriko Takeda(Yokohama City University), Hideya Kitamura(Kanagawa Cardiovascular and Respiratory Center), Hideki Hasegawa(University of California, Los Angeles), Eri Hagiwara(Kanagawa Cardiovascular and Respiratory Center), Takashi Ogura(Kanagawa Cardiovascular and Respiratory Center), Ichiro Takeuchi(Yokohama City University), Kouji Yamamoto(Yokohama City University), Tomohiko Tamura(Yokohama City University Medical Center), Yusuke Nakai(Yokohama City University Medical Center), Kazuya Sakai(Yokohama City University), Sousuke Kubo(Yokohama City University), Miyui Hara(Yokohama City University)
Cited by 65
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Single Nigrostriatal Dopaminergic Neurons Form Widely Spread and Highly Dense Axonal Arborizations in the Neostriatum
|Journal of Neuroscience|2009|874
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
|Nature Medicine|2020|366
Confidence interval for micro-averaged F1 and macro-averaged F1 scores
|Applied Intelligence|2021|273